Revenue for Helix Biomedix Decreases by -31.77% even though Revenue for Biotech and Medical Products Industry Increases by 10.54% over Latest 12 Months
Stock Quote:(N/A:HXBM)
11/16/2009
0.00
N/A
N/A
Revenue for Helix Biomedix Decreases by -31.77% even though Revenue for Biotech and Medical Products Industry Increases by 10.54% over Latest 12 Months
Last
Price Change
% Chg
Volume
New York, New York, November 16, 2009,T12-NEWS reports that Revenue for Helix Biomedix (OTC:HXBM) for its trailing twelve months (TTM) ended September 30, 2009 decreased by -31.77% to $402,307, from i ... read full story
U.S. stocks ended modestly lower as Greece continued to overhang the markets today. Greece missed another deadline today to respond to austerity terms of a new EU/IMF bailout. Leaders of the political parties in Greece's coalition government were una ... read full story